Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ADALIMUMAB-RYVK vs ADAPALENE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ADALIMUMAB-RYVK vs ADAPALENE: Safety Overview

Metric ADALIMUMAB-RYVK ADAPALENE
Total FAERS Reports 463 181,442
Deaths Reported 48 6
Death Rate 10.4% 0.0%
Hospitalizations 112 68
Average Patient Age 50.0 yrs 24.3 yrs
% Female Patients 63.0% 78.5%
FDA Approval Date N/A Jan 14, 2022
Manufacturer A-S Medication Solutions Galderma Laboratories, L.P.
Route SUBCUTANEOUS TOPICAL
Marketing Status Prescription Discontinued